Amicogen, Inc. (092040.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenKRW 910.00

From 52W high−78.48%

Volume244921.00

Market capKRW 50.60B

P/E (TTM)—

P/S (TTM)1.1x

Div yield—

Key dataSep 18, 2026

Open

KRW 910.00

From 52W high

−78.48%

Volume

244921.00

Market cap

KRW 50.60B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−11.2x

P/E (TTM)

—

RSI (14)

40.8

MomentumView details →

1D Return

+2.71%

YTD Return

−49.49%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−11.2x

EV/Sales

2.2x

P/S (TTM)

1.1x

P/B (TTM)

0.4x

ProfitabilityView details →

Gross Margin

13.79%

Net Margin

−41.34%

EBITDA Margin

−19.28%

ROE (TTM)

−16.35%

ROA (TTM)

−9.78%

Asset Turnover

0.23x

GrowthView details →

Revenue YoY

−60.35%

EPS YoY

+65.74%

FCF YoY

+96.15%

Revenue CAGR 3Y

−33.74%

EPS CAGR 3Y

+43.93%

EBITDA YoY

+60.47%

MomentumView details →

1D Return

+2.71%

YTD Return

−49.49%

1Y Return

−77.50%

RSI (14)

40.8

vs 50D SMA

−13.97%

vs 200D SMA

−42.57%

Capital & dividendView details →

Debt/Equity

0.50x

Current Ratio

1.04x

Quick Ratio

0.81x

Div Yield

—

Div Rate

—

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

46.67B

Net Income (TTM)

−19.29B

Op. CF (TTM)

−606.32M

Next earningsDec 14, 2026 →

Latest newsMore news →

No recent news for 092040.KQ.

Similar companies

艾力斯688578.SH Pharmaron Beijing Co., Ltd.03759.HK GeneOne Life Science, Inc.011000.KS Asymchem Laboratories (Tianjin) Co., Ltd.06821.HK Encell Co. Ltd.456070.KQ RemeGen Co., Ltd.09995.HK Find similar companies →

Latest newsMore news →

No recent news for 092040.KQ.